Eiichi Hinoi1,2,3

  • 1Department of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University.

PubMed
概括

质瘤干细胞 (GSCs) 中的两种蛋白质修饰会影响质母细胞瘤 (GBM) 恶性. 了解SMURF2和MEK5通路为由癌症干细胞驱动的癌症提供了潜在的治疗点.